EU-Startups
Dutch-based TargED raises €21.5 million Series A extension to advance targeted treatments for thrombotic diseases
Dutch clinical-stage BioTech company TargED Biopharmaceuticals has announced the closing of a €21.5 million Series A extension financing to accelerate the clinical development of its targeted […]
